11th International Conference on Cancer-Induced Bone Disease in Chicago, IL, in p

描述(申请人提供)：第十一届国际癌症骨病会议将于2011年11月30日至12月3日在美国芝加哥举行。国际骨与矿物学会(IBMS)、癌症与骨学会(CABS-IBMS的一个项目)和骨与癌症基金会(BCF)共同在本次会议上就创新治疗和尖端科学的最新进展进行了高层讨论。世界领先的科学家和研究人员将分享他们在骨转移、癌症骨骼并发症以及骨和癌细胞生物学方面的专业知识。科学计划委员会成员包括Philippi Clezardin、Theresa Guise、Dominique Heymann、Peter Croucher、G.David Roodman、Michael Gnant、宜宾·康、Matthew Smith和Gabri van der Pluijm。主题包括癌症干细胞(转移与癌症治疗)、microRNA(非编码RNA与癌症)、转移前利基、播散性肿瘤细胞肿瘤休眠、侵袭和转移、上皮-间充质转变、体内非侵入性成像技术、分子靶向治疗、将试验结果转化为临床实践、治疗耐药性、合成代谢制剂、原发骨肿瘤及肿瘤相关间质。会议积极促进青年研究人员和该领域新兴领导者的参与，提供青年研究人员奖和旅行补助金，并提供与国际领先研究人员见面和建立联系的机会。青年研究人员是2011年会议的重要焦点，特别设计了一个项目，为展示开创性的青年研究人员的研究提供一个场所，并促进与更有经验的同行和知名导师的多重互动。这次会议的规模很小，这确保了青年调查人员的突出地位，并使这一会议对他们来说是一次有价值的会议。 公共卫生意义：第11届国际癌症骨病大会由国际骨与矿物学会(IBMS)、癌症与骨学会(CABS)、骨与癌症基金会(BCF)及其上级组织Paget Foundation共同主办，将于2011年11月30日至12月3日在芝加哥的威斯汀密歇根大道举行。CIBD和BCF/Paget会议在提供最新的转移性骨疾病科学和临床研究方面有着悠久的历史，有300多名科学家和临床医生参加，并继续成为骨肿瘤学的首要会议，吸引了来自世界各地的与会者。使命：IBMS是一个国际组织，通过在世界各地的交流、社区、培训和多学科会议，促进骨和矿物质代谢知识的产生和传播。

DESCRIPTION (provided by applicant): The 11th International Conference on Cancer-Induced Bone Disease (CIBD) will be held November 30 - December 3, 2011 in Chicago, USA. The International Bone and Mineral Society (IBMS), the Cancer and Bone Society (CABS - a program of IBMS) and the Bone and Cancer Foundation (BCF) jointly present this meeting with high-level discussions on the latest advances in innovative treatments and cutting-edge science. The world's leading scientists and researchers will share their expertise in bone metastases, skeletal complications of cancer, and bone and cancer cell biology. Scientific Program Committee includes Philippi Clezardin, Theresa Guise, Dominique Heymann, Peter Croucher, G. David Roodman, Michael Gnant, Yibin Kang, Matthew Smith and Gabri van der Pluijm. Topics include Cancer Stem Cells (Metastasis and Cancer Therapy, MicroRNA (Non-coding RNAs and Cancer), Premetastatic Niche, Disseminated Tumor Cell Tumor Dormancy, Invasion and Metastasis, Epithelial-mesenchymal transition, In vivo noninvasive Imaging Technologies, Molecularly Targeted Therapies, Translating Trial Results into Clinical Practice, Therapy Resistance, Anabolic Agents, Primary Bone Tumors and Tumor-associated Stroma. The meeting proactively fosters the participation of young investigators and emerging leaders in the field by providing young investigator awards and travel grants, and opportunities for meeting and networking with leading international researchers. Young Investigators are the important focus of the 2011 meeting, with a program especially designed to provide a venue for the presentation of research from ground-breaking Young Investigators, and to foster multiple interactions with their more experienced peers and established mentors. The small size of this meeting assures Young Investigators a prominent place and makes this a valuable meeting for them. PUBLIC HEALTH RELEVANCE: The 11th International Conference on Cancer-Induced Bone Disease is presented by the International Bone and Mineral Society (IBMS), with the Cancer and Bone Society (CABS), the Bone and Cancer Foundation (BCF) and its parent organization, the Paget Foundation, and will take place November 30 - December 3, 2011 at the Westin Michigan Avenue in Chicago. The CIBD and BCF/Paget conferences have a long history of providing the most current scientific and clinical research in metastatic bone disease, are attended by more than 300 scientists and clinicians, and continue to be the premier meetings in bone oncology, attracting attendees from around the world. MISSION: IBMS is the international organization that facilitates the generation and dissemination of knowledge of bone and mineral metabolism through communication, community, training, and multi-disciplinary meetings throughout the world.